Cellebrite DI Ltd (CLBT) FinancialsCLBTCellebrite DI Ltd

Evaluating the bottom line, Cellebrite DI Ltd maintains a gross margin of 80.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.82%, while the net margin is 4.86%. These profitability ratios, combined with a Return on Equity (ROE) of 12.31%, provide a clear picture of how effectively CLBT converts its operational activities into shareholder value.

In the context of the broader market, CLBT competes directly with industry leaders such as NTCT and LFTO. With a market capitalization of $2.83B, it holds a leading position in the sector. When comparing efficiency, CLBT's gross margin of 80.78% stands against NTCT's 73.81% and LFTO's 76.31%. Such benchmarking helps identify whether Cellebrite DI Ltd is trading at a premium or discount relative to its financial performance.

Cellebrite reported a gross margin of 80.78% in Q2 2026, reflecting strong profitability despite recent challenges. However, net income has decreased significantly, with Q2 2026 net income dropping to $6.37 million from $20.74 million in Q4 2025, indicating potential issues with profitability.